Citations (165)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ping Jin, Kui Wang, Canhua Huang & Edouard C. Nice. (2017) Mining the fecal proteome: from biomarkers to personalised medicine. Expert Review of Proteomics 14:5, pages 445-459.
Read now
Read now
Nea Malila, Matti Hakama & Eero Pukkala. (2007) A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncologica 46:8, pages 1103-1106.
Read now
Read now
Matti Hakama, Geir Hoff, Ole Kronborg & Lars Påhlman. (2005) Screening for colorectal cancer. Acta Oncologica 44:5, pages 425-439.
Read now
Read now
John B. Edwards, J. Anthony R. Williams & David W. Thomas. (2004) Experiences in providing a screening service for colorectal cancer from a pathology laboratory. Pathology 36:4, pages 330-334.
Read now
Read now
E. Lindholm, B. Berglund, J. Kewhnter & E. Haglind. (1997) Worry Associated with Screening for Colorectal Carcinomas. Scandinavian Journal of Gastroenterology 32:3, pages 238-245.
Read now
Read now
E. Lindholm, B. Berglund, E. Haglind & J. Kewenter. (1995) Factors Associated with Participation in Screening for Colorectal Cancer with Faecal Occult Blood Testing. Scandinavian Journal of Gastroenterology 30:2, pages 171-176.
Read now
Read now
Articles from other publishers (159)
Rajani Pokharel, Yi-Shu Lin, Ethna McFerran & James F. O’Mahony. (2023) A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?. Applied Health Economics and Health Policy 21:5, pages 701-717.
Crossref
Crossref
Ann G. Zauber, Sidney J. Winawer, Michael J. O’Brien, Glenn M. Mills, John I. Allen, Andrew D. Feld, Paul A. Jordan, Martin Fleisher, Irene Orlow, Reinier G.S. Meester, Iris Lansdorp-Vogelaar, Carolyn M. Rutter, Amy B. Knudsen, Margaret Mandelson, Aasma Shaukat, Robin B. Mendelsohn, Anne I. Hahn, Stephanie M. Lobaugh, Brittany Soto Palmer, Victoria Serrano, Julie R. Kumar, Sara E. Fischer, Jennifer C. Chen, Sharon Bayuga-Miller, Deborah Kuk, Kelli O’Connell & Timothy R. Church. (2023) Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test. Gastroenterology 165:1, pages 252-266.
Crossref
Crossref
Lauro Bucchi, Silvia Mancini, Flavia Baldacchini, Alessandra Ravaioli, Orietta Giuliani, Rosa Vattiato, Federica Zamagni, Paolo Giorgi Rossi, Cinzia Campari, Debora Canuti, Enza Di Felice, Priscilla Sassoli de Bianchi, Stefano Ferretti, Nicoletta Bertozzi, Annibale Biggeri, Fabio Falcini, Enza Di Felice, Alba Carola Finarelli, Patrizia Landi, Carlo Naldoni, Priscilla Sassoli de Bianchi, Americo Colamartini, Elisabetta Borciani, Fabio Fornari, Giorgio Gatti, Francesca Pennini, Pietro Seghini, Cristian Dalla Fiora, Claudio Fattibene, Fabio Maradini, Maria Michiara, Paolo Orsi, Corrado Zurlini, Lucia Mangone, Luisa Paterlini, Romano Sassatelli, Giuliano Carrozzi, Rossella Corradini, Federica Rossi, Paolo Trande, Simona Viani, Carmen Bazzani, Franco Bazzoli, Vincenzo Cennamo, Chiara Giansante, Giovanna Gualandi, Marilena Manfredi, Francesca Mezzetti, Adriana Pasquini, Licia Caprara, Margherita De Lillo, Roberto Nannini, Maria Cristina Carpanelli, Aldo De Togni, Vincenzo Matarese, Caterina Palmonari, Daniela Pasquali, Giorgio Zoli, Serena Dal Re, Chiara Petrini, Monica Serafini, Benedetta Vitali, Mara Gallinucci, Claudia Imolesi, Mauro Palazzi, Enrico Ricci, Mirna Severi, Coralba Casale, Mauro Giovanardi & Daniele Trombetti. (2022) How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study. British Journal of Cancer 127:3, pages 541-548.
Crossref
Crossref
Yanmin Li, Hong Cao, Bojian Fei, Qizhong Gao, Wanya Yi, Weifeng Han, Chuanqing Bao, Jianmin Xu, Wei Zhao & Feng Zhang. (2022) Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
V. Paul Doria‐Rose, Iris Lansdorp‐Vogelaar, Sharon McCarthy, Douglas M. Puricelli‐Perin, Vicent Butera, Nereo Segnan, Stephen H. Taplin & Carlo Senore. (2021) Measures of longitudinal adherence to fecal‐based colorectal cancer screening: Literature review and recommended approaches. International Journal of Cancer 149:2, pages 316-326.
Crossref
Crossref
Jennifer S. Lin, Leslie A. Perdue, Nora B. Henrikson, Sarah I. Bean & Paula R. Blasi. (2021) Screening for Colorectal Cancer. JAMA 325:19, pages 1978.
Crossref
Crossref
Jason Kim, Benjamin Dobson, Cedric Ng Liet Hing, Michelle Cooper, Cu Tai Lu, Gregory Nolan & Michael Von Papen. (2020) Increasing rate of colorectal cancer in younger patients: a review of colonoscopy findings in patients under 50 at a tertiary institution. ANZ Journal of Surgery 90:12, pages 2484-2489.
Crossref
Crossref
L.J.W. BoschV. MelotteS. MongeraK.L.J. DaenenV.M.H. CoupéS.T. van TurenhoutE.M. StoopT.R. de WijkersloothC.J.J. MulderC. RauschE.J. KuipersE. DekkerM.J. DomanicoG.P. LidgardB.M. BergerM. van EngelandB. CarvalhoG.A. Meijer. (2019) Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. American Journal of Gastroenterology 114:12, pages 1909-1918.
Crossref
Crossref
Henriette C Jodal, Lise M Helsingen, Joseph C Anderson, Lyubov Lytvyn, Per Olav Vandvik & Louise Emilsson. (2019) Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open 9:10, pages e032773.
Crossref
Crossref
Johannes Blom, Christian Löwbeer, K. Miriam Elfström, Marika Sventelius, Daniel Öhman, Deborah Saraste & Sven Törnberg. (2018) Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. Journal of Medical Screening 26:2, pages 92-97.
Crossref
Crossref
E. Mozdiak, A. N. Wicaksono, J. A. Covington & R. P. Arasaradnam. (2019) Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP). Techniques in Coloproctology 23:4, pages 343-351.
Crossref
Crossref
Fadi Antaki, Stephanie Judd, Ziad Kanaan, Suhag M. Patel & Kirthi K. Lilley. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology
573
593
.
Mark B. Pochapin. (2018) 2017 Emily Couric Memorial Lecture: Colorectal Cancer: Polyps, Prevention, and Progress. American Journal of Gastroenterology 113:12, pages 1772-1777.
Crossref
Crossref
Jennifer A Cuthbert & Ibrahim A Hashim. (2018) Diagnostic Fecal Occult Blood Testing in Hospitalized and Emergency Department Patients: Time for Change?. Laboratory Medicine 49:4, pages 385-392.
Crossref
Crossref
Roisin Bevan & Matthew D Rutter. (2018) Colorectal Cancer Screening—Who, How, and When?. Clinical Endoscopy 51:1, pages 37-49.
Crossref
Crossref
Santiago Esteban, Ricardo Ricci, Sergio Terrasa & Karin Kopitowski. (2017) Colonoscopy overuse in colorectal cancer screening and associated factors in Argentina: a retrospective cohort study. BMC Gastroenterology 17:1.
Crossref
Crossref
Sally C Benton, Piers Butler, Katy Allen, Michelle Chesters, Sally Rickard, Sally Stanley, Richard Roope, Daniel Vulkan & Stephen W Duffy. (2017) GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. British Journal of Cancer 116:12, pages 1551-1557.
Crossref
Crossref
Georgia M. Beasley, Zhifei Sun, Daniel P. Nussbaum & Douglas S. Tyler. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
32
.
Uri Ladabaum & Ajitha Mannalithara. (2016) Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology 151:3, pages 427-439.e6.
Crossref
Crossref
Jasper L.A. Vleugels, Meta C.J. van Lanschot & Evelien Dekker. (2016) Colorectal cancer screening by colonoscopy: putting it into perspective. Digestive Endoscopy 28:3, pages 250-259.
Crossref
Crossref
. (2016) Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program. Asia-Pacific Journal of Clinical Oncology 12:1, pages 22-32.
Crossref
Crossref
Kathleen M Decker, Alain A Demers, Zoann Nugent, Natalie Biswanger & Harminder Singh. (2016) Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba. BMJ Open 6:2, pages e009470.
Crossref
Crossref
Benjamin Kearns, Sophie Whyte, Helen E Seaman, Julia Snowball, Stephen P Halloran, Piers Butler, Julietta Patnick, Claire Nickerson & Jim Chilcott. (2016) Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm. British Journal of Cancer 114:3, pages 327-333.
Crossref
Crossref
Mariann Rutka, Renáta Bor, Anita Bálint, Anna Fábián, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Mónika Szűcs, László Tiszlavicz, Klaudia Farkas & Tamás Molnár. (2016) Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum. Mediators of Inflammation 2016, pages 1-6.
Crossref
Crossref
Timothy J. O’Leary, Jason A. Dominitz & Kyong-Mi Chang. (2015) Veterans Affairs Office of Research and Development: Research Programs and Emerging Opportunities in Digestive Diseases Research. Gastroenterology 149:7, pages 1652-1661.
Crossref
Crossref
Uri Ladabaum. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1608
1628
.
Hari Padmanabhan, Monika Widlak, Alan Nevill, Brian McKaig, Matthew Brookes & Andrew Veitch. (2015) Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre. European Journal of Gastroenterology & Hepatology 27:11, pages 1281-1285.
Crossref
Crossref
Paolo Giorgi Rossi, Massimo Vicentini, Claudio Sacchettini, Enza Di Felice, Stefania Caroli, Francesca Ferrari, Lucia Mangone, Annamaria Pezzarossi, Francesca Roncaglia, Cinzia Campari, Romano Sassatelli, Roberto Sacchero, Giuliana Sereni, Luisa Paterlini & Marco Zappa. (2015) Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy. American Journal of Gastroenterology 110:9, pages 1359-1366.
Crossref
Crossref
C. Arsov, N. Becker & P. Albers. (2015) Risikoadaptiertes PSA-Screening und die PROBASE-StudieRisk-adapted PSA screening and the PROBASE trial. Der Onkologe 21:9, pages 778-786.
Crossref
Crossref
Luis Bujanda, Cristina Sarasqueta, Antoni Castells, María Pellisé, Joaquín Cubiella, Inés Gil, Angel Cosme, Eunate Arana-Arri, Izaskun Mar, Isabel Idigoras & Isabel Portillo. (2015) Colorectal cancer in a second round after a negative faecal immunochemical test. European Journal of Gastroenterology & Hepatology 27:7, pages 813-818.
Crossref
Crossref
Manuel Zorzi, Ugo Fedeli, Elena Schievano, Emanuela Bovo, Stefano Guzzinati, Susanna Baracco, Chiara Fedato, Mario Saugo & Angelo Paolo Dei Tos. (2015) Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 64:5, pages 784-790.
Crossref
Crossref
Andy Veitch & Matt Rutter. (2015) Improving quality in endoscopy: are we nearly there yet?. Frontline Gastroenterology 6:2, pages 127-131.
Crossref
Crossref
B. Joseph Elmunzer, Amit G. Singal, Jeremy B. Sussman, Amar R. Deshpande, Daniel A. Sussman, Marisa L. Conte, Ben A. Dwamena, Mary A.M. Rogers, Philip S. Schoenfeld, John M. Inadomi, Sameer D. Saini & Akbar K. Waljee. (2015) Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointestinal Endoscopy 81:3, pages 700-709.e3.
Crossref
Crossref
Sally C. Benton, Helen E. Seaman & Stephen P. Halloran. (2015) Faecal Occult Blood Testing for Colorectal Cancer Screening: the Past or the Future. Current Gastroenterology Reports 17:2.
Crossref
Crossref
Dae Kyung Sohn, Min Ju Kim, Younhee Park, Mina Suh, Aesun Shin, Hee Young Lee, Jong Pil Im, Hyoen-Min Cho, Sung Pil Hong, Baek-hui Kim, Yongsoo Kim, Jeong Wook Kim, Hyun-Soo Kim, Chung Mo Nam, Dong Il Park, Jun Won Um, Soon Nam Oh, Hwan Sub Lim, Hee Jin Chang, Sang Keun Hahm, Ji Hye Chung, Soo Young Kim, Yeol Kim, Won-Chul Lee & Seung-Yong Jeong. (2015) The Korean guideline for colorectal cancer screening. Journal of the Korean Medical Association 58:5, pages 420.
Crossref
Crossref
Yuka Kobayashi. (2015) Impact of fecal occult blood on obscure gastrointestinal bleeding: Observational study. World Journal of Gastroenterology 21:1, pages 326.
Crossref
Crossref
S. Wortley, G. Wong, A. Kieu & K. Howard. (2014) Assessing Stated Preferences for Colorectal Cancer Screening: A Critical Systematic Review of Discrete Choice Experiments. The Patient - Patient-Centered Outcomes Research 7:3, pages 271-282.
Crossref
Crossref
Magdalen R.R. Carroll, Helen E. Seaman & Stephen P. Halloran. (2014) Tests and investigations for colorectal cancer screening. Clinical Biochemistry 47:10-11, pages 921-939.
Crossref
Crossref
Jacques Rouëssé & Hélène Sancho-Garnier. (2014) Le dépistage organisé des cancers colorectaux. Bulletin de l'Académie Nationale de Médecine 198:2, pages 387-399.
Crossref
Crossref
José Cruzado, Fernando I. Sánchez, José María Abellán, Francisco Pérez-Riquelme & Fernando Carballo. (2013) Economic evaluation of colorectal cancer (CRC) screening. Best Practice & Research Clinical Gastroenterology 27:6, pages 867-880.
Crossref
Crossref
Øyvind Holme, Michael Bretthauer, Atle Fretheim, Jan Odgaard-Jensen & Geir Hoff. (2013) Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews 2014:3.
Crossref
Crossref
Aasma Shaukat, Steven J. Mongin, Mindy S. Geisser, Frank A. Lederle, John H. Bond, Jack S. Mandel & Timothy R. Church. (2013) Long-Term Mortality after Screening for Colorectal Cancer. New England Journal of Medicine 369:12, pages 1106-1114.
Crossref
Crossref
M.J. Denters, M. Deutekom, P.M. Bossuyt, A.F. van Rijn, P. Fockens & E. Dekker. (2013) Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening. Cancer Epidemiology 37:3, pages 330-335.
Crossref
Crossref
Mairead Skally, Paul Hanly & Linda Sharp. (2013) Cost Effectiveness of Fecal DNA Screening for Colorectal Cancer: A Systematic Review and Quality Appraisal of the Literature. Applied Health Economics and Health Policy 11:3, pages 181-192.
Crossref
Crossref
Beatriz Carvalho, Linda JW Bosch, Manon Van Engeland & Gerrit A Meijer. (2013) Molecular markers and the future of colorectal cancer screening. Colorectal Cancer 2:2, pages 95-97.
Crossref
Crossref
Dea Grip Riboe, Tilde Steen Dogan & John Brodersen. (2013) Potential biases in colorectal cancer screening using faecal occult blood test. Journal of Evaluation in Clinical Practice 19:2, pages 311-316.
Crossref
Crossref
Ernst J. Kuipers, Thomas Rösch & Michael Bretthauer. (2013) Colorectal cancer screening—optimizing current strategies and new directions. Nature Reviews Clinical Oncology 10:3, pages 130-142.
Crossref
Crossref
U. Damian, D. Schilling & J.F. Riemann. (2012) Vorsorge gastrointestinaler TumorenPrevention of gastrointestinal tumors. Der Gastroenterologe 7:6, pages 531-540.
Crossref
Crossref
S. A. Suttie, I. A. Shaikh, A. I. Amin, T. Daniel & S. Yalamarthi. (2012) The effect of a screening programme on the outcome of colorectal cancer. Colorectal Disease 14:8, pages 937-942.
Crossref
Crossref
Oliver Peacock, Edward S. Watts, Nader Hanna, Keren Kerr, Andrew F. Goddard & Jonathan N. Lund. (2012) Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme. European Journal of Gastroenterology & Hepatology, pages 1.
Crossref
Crossref
M D Gill, M G Bramble, C J Rees, T J W Lee, D M Bradburn & S J Mills. (2012) Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. British Journal of Cancer 107:3, pages 417-421.
Crossref
Crossref
G Libby, D H Brewster, P L McClements, F A Carey, R J Black, J Birrell, C G Fraser & R J C Steele. (2012) The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. British Journal of Cancer 107:2, pages 255-259.
Crossref
Crossref
Chelliah R. Selvasekar, Stefan D. Holubar, Rajesh Pendlimari, Gregory D. Kennedy, William S. Harmsen, Jeff R. Harrington & Heidi Nelson. (2012) Assessment of Screening Colonoscopy Competency in Colon and Rectal Surgery Fellows: A Single Institution Experience. Journal of Surgical Research 174:1, pages e17-e23.
Crossref
Crossref
Juan Diego Morillas, Antoni Castells, Isabel Oriol, Ana Pastor, Pedro Pérez-Segura, José Manuel Echevarría, Begoña Caballero, Andrés González-Navarro, Fernando Bandrés, Enric Brullet, Antonio Iniesta, Fernando Carballo, Rosa Bouzas, Aurelio Ariza, Alfredo Ibisate, Pilar García-Alfonso, Beatriz Escudero, Silvia Camacho, Ana Fernández-Marcos, Teresa González, Enrique Quintero, Ángel Lanas, Mercè Marzo, Juanjo Mascort, Monserrat Andréu, Laura Cerezo, Enrique Vázquez-Sequeiros, Josep María Borrás, Dolores Salas, Nieves Ascunce, Isabel Portillo, Mayte Herráiz, María Luisa Valle, Amalia Sotoca, Santiago Nieto, Carlos Hué & Luis Paz-Ares. (2012) Alianza para la Prevención del Cáncer de Colon en España: un compromiso cívico con la sociedad. Gastroenterología y Hepatología 35:3, pages 109-128.
Crossref
Crossref
K. F. Newton, W. Newman & J. Hill. (2012) Review of biomarkers in colorectal cancer. Colorectal Disease 14:1, pages 3-17.
Crossref
Crossref
Aafke HC van Roon, Lieke Hol, Anneke J van Vuuren, Jan Francke, Martine Ouwendijk, Angela Heijens, Nicole Nagtzaam, Jacqueline CIY Reijerink, Alexandra CM van der Togt, Marjolein van Ballegooijen, Ernst J Kuipers & Monique E van Leerdam. (2012) Are Fecal Immunochemical Test Characteristics Influenced by Sample Return Time? A Population-Based Colorectal Cancer Screening Trial. American Journal of Gastroenterology 107:1, pages 99-107.
Crossref
Crossref
Susan K. Clark. 2012. Contemporary Coloproctology. Contemporary Coloproctology
109
121
.
Barbara-Ann Adelstein, Petra Macaskill, Robin M Turner, Peter H Katelaris & Les Irwig. (2011) The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterology 11:1.
Crossref
Crossref
Andrew R. Hart & Hugh J. Kennedy. (2011) Preventing bowel cancer: an insight for clinicians. Therapeutic Advances in Medical Oncology 3:6, pages 269-277.
Crossref
Crossref
Imran M Patanwala, Victoria Brocklebank, Janet Inglis & Peter N Trewby. (2011) A randomized questionnaire based study on the impact of providing numerical information on colorectal cancer screening. JRSM Short Reports 2:6, pages 1-9.
Crossref
Crossref
M. Shuhaibar, C. Walsh, F. Lindsay, N. Lee, P. Walsh, P. O’Gorman, G. Boran, R. McLoughlin, A. Qasim, N. Breslin, B. Ryan, H. O’Connor & C. O’Morain. (2010) A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers. Irish Journal of Medical Science 180:1, pages 103-108.
Crossref
Crossref
Nabil Fayad & Thomas F. Imperiale. 2011. Colorectal Cancer Screening. Colorectal Cancer Screening
123
150
.
Michael J. Duffy, Leo G. M. van Rossum, Sietze T. van Turenhout, Outi Malminiemi, Catherine Sturgeon, Rolf Lamerz, Andrea Nicolini, Caj Haglund, Lubos Holubec, Callum G. Fraser & Stephen P. Halloran. (2010) Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. International Journal of Cancer 128:1, pages 3-11.
Crossref
Crossref
Ching‐Seng Ang, Jason Phung & Edouard C. Nice. (2010) The discovery and validation of colorectal cancer biomarkers. Biomedical Chromatography 25:1-2, pages 82-99.
Crossref
Crossref
Shwetal Dighe, Mirza Khurrum Baig, Anthony Miles, Malcolm McFall & Parvinder Sains. (2010) Colorectal cancer screening. Clinical Risk 16:6, pages 226-230.
Crossref
Crossref
B L Frederiksen, T Jørgensen, K Brasso, I Holten & M Osler. (2010) Socioeconomic position and participation in colorectal cancer screening. British Journal of Cancer 103:10, pages 1496-1501.
Crossref
Crossref
Monika Janda, Karen L Hughes, Josephine F Auster, Barbara A Leggett & Beth M Newman. (2010) Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting. Journal of Gastroenterology and Hepatology 25:10, pages 1661-1667.
Crossref
Crossref
H Paimela, N Malila, T Palva, T Hakulinen, H Vertio & H Järvinen. (2010) Early detection of colorectal cancer with faecal occult blood test screening. British Journal of Surgery 97:10, pages 1567-1571.
Crossref
Crossref
P. Ellul, E. Fogden, C. L. Simpson, C. L. R. Nickerson, B. C. Mckaig, E. T. Swarbrick & A. M. Veitch. (2010) Downstaging of colorectal cancer by the national bowel cancer screening programme in England: first round data from the first centre. Colorectal Disease 12:5, pages 420-422.
Crossref
Crossref
David Lieberman. (2010) Progress and Challenges in Colorectal Cancer Screening and Surveillance. Gastroenterology 138:6, pages 2115-2126.
Crossref
Crossref
L Hol, E W de Bekker-Grob, L van Dam, B Donkers, E J Kuipers, J D F Habbema, E W Steyerberg, M E van Leerdam & M L Essink-Bot. (2010) Preferences for colorectal cancer screening strategies: a discrete choice experiment. British Journal of Cancer 102:6, pages 972-980.
Crossref
Crossref
Takuji Ozaki, Akira Tokunaga, Naoto Chihara, Masanori Yoshino, Hideki Bou, Masao Ogata, Masanori Watanabe, Hideyuki Suzuki & Eiji Uchida. (2010) Total Colonoscopy Detects Early Colorectal Cancer More Frequently than Advanced Colorectal Cancer in Patients with Fecal Occult Blood. Journal of Nippon Medical School 77:4, pages 195-203.
Crossref
Crossref
Enrique Quintero. (2009) ¿Test químico o test inmunológico para la detección de sangre oculta en heces en el cribado del cáncer colorrectal?. Gastroenterología y Hepatología 32:8, pages 565-576.
Crossref
Crossref
James E. Allison & Michael B. Potter. (2009) New Screening Guidelines for Colorectal Cancer: A Practical Guide for the Primary Care Physician. Primary Care: Clinics in Office Practice 36:3, pages 575-602.
Crossref
Crossref
J. Faivre, C. Lepage & J. Viguier. (2009) Cancer colorectal : du diagnostic au dépistage. Gastroentérologie Clinique et Biologique 33:8-9, pages 660-671.
Crossref
Crossref
F Parente, B Marino, N DeVecchi & R Moretti. (2009) Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. British Journal of Surgery 96:5, pages 533-540.
Crossref
Crossref
Ali Tafazzoli, Stephen Roberts, Robert Klein, Reid Ness & Robert Dittus. (2009) Probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer. ACM Transactions on Modeling and Computer Simulation 19:2, pages 1-29.
Crossref
Crossref
D A L Macafee, M Waller, D K Whynes, S Moss & J H Scholefield. (2008) Population screening for colorectal cancer: the implications of an ageing population. British Journal of Cancer 99:12, pages 1991-2000.
Crossref
Crossref
E Lindholm, H Brevinge & E Haglind. (2008) Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. British Journal of Surgery 95:8, pages 1029-1036.
Crossref
Crossref
Paul Hewitson, Paul Glasziou, Eila Watson, Bernie Towler & Les Irwig. (2008) Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update. The American Journal of Gastroenterology 103:6, pages 1541-1549.
Crossref
Crossref
Jack S. Mandel. (2008) Screening for Colorectal Cancer. Gastroenterology Clinics of North America 37:1, pages 97-115.
Crossref
Crossref
A. Eickhoff, D. Hartmann, J. Striegel & J.F. Riemann. (2008) Früherkennung und Primärprävention des DickdarmkrebsesEarly detection and primary prevention of colorectal cancer. Der Onkologe 14:2, pages 131-141.
Crossref
Crossref
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon
897
940
.
Federico Sopeña, Angel Ferrandez & Angel Lanas. (2008) Noninvasive diagnostic modalities for early detection of colorectal cancer. Current Colorectal Cancer Reports 4:1, pages 24-33.
Crossref
Crossref
Pierluigi Fracasso & Massimo Crespi. 2008. La colonscopia virtuale. La colonscopia virtuale
3
14
.
Mark L. Welton, Andrew A. Shelton, George J. Chang & Madhulika G. Varma. 2008. Surgery. Surgery
1011
1110
.
Stacy E. F. Melanson & Kent B. Lewandrowski. (2007) The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Occult Blood Testing. Point of Care: The Journal of Near-Patient Testing & Technology 6:4, pages 243-246.
Crossref
Crossref
Sidney J. Winawer. (2007) Colorectal cancer screening. Best Practice & Research Clinical Gastroenterology 21:6, pages 1031-1048.
Crossref
Crossref
Lara Maria Pasetto & Silvio Monfardini. (2007) Colorectal cancer screening in elderly patients: When should be more useful?. Cancer Treatment Reviews 33:6, pages 528-532.
Crossref
Crossref
A. Eickhoff, J. Striegel & J.F. Riemann. (2007) Kolorektales KarzinomColorectal cancer. Der Gastroenterologe 2:5, pages 339-349.
Crossref
Crossref
J. Faivre, V. Dancourt & N. Touillon. (2007) Le dépistage du cancer colorectal Etat des connaissances, mise en place en FranceScreening of colorectal cancer State of the art and implementation in France. Acta Endoscopica 37:2, pages 119-130.
Crossref
Crossref
Konstantinos Kamposioras, Davide Mauri, Vassilis Golfinopoulos, Georgios Ferentinos, Georgios Zacharias, Apostolos Xilomenos, Nikolaos P. Polyzos, Magdalini Bristianou, Dimitra Chasioti, Athanasios Milousis, Angeliki Vittoraki, Georgios Koukourakis, Ioanna Chatziioannou & Panagiotis Papadopoulos. (2006) Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration. International Journal of Colorectal Disease 22:5, pages 475-481.
Crossref
Crossref
Paul Hewitson, Paul P Glasziou, Les Irwig, Bernie Towler & Eila Watson. (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews 2011:2.
Crossref
Crossref
Apostolos Xilomenos, Davide Mauri, Konstantinos Kamposioras, Athanasia Gkinosati, Georgios Zacharias, Varvara Sidiropoulou, Panagiotis Papadopoulos, Georgios Chatzimichalis, Vassilis Golfinopoulos & Christina Peponi. (2006) Colorectal cancer screening awareness among physicians in Greece. BMC Gastroenterology 6:1.
Crossref
Crossref
Michael V. Maciosek, Leif I. Solberg, Ashley B. Coffield, Nichol M. Edwards & Michael J. Goodman. (2006) Colorectal Cancer Screening. American Journal of Preventive Medicine 31:1, pages 80-89.
Crossref
Crossref
David A. Etzioni, Elizabeth M. Yano, Lisa V. Rubenstein, Martin L. Lee, Clifford Y. Ko, Robert H. Brook, Patricia H. Parkerton & Steven M. Asch. (2006) Measuring the Quality of Colorectal Cancer Screening: The Importance of Follow-Up. Diseases of the Colon & Rectum 49:7, pages 1002-1010.
Crossref
Crossref
Michael R. Thompson, Robert J. C. Steele & W. S. Atkin. (2006) Effective Screening for Bowel Cancer: A United Kingdom Perspective. Diseases of the Colon & Rectum 49:6, pages 895-908.
Crossref
Crossref
S. Tong, K. Hughes, B. Oldenburg & CD Mar. (2016) Colorectal Cancer Screening with Faecal Occult Blood Testing: Community Intention, Knowledge, Beliefs and Behaviour. Asia Pacific Journal of Public Health 18:1, pages 16-23.
Crossref
Crossref
. (2006) Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data. The American Journal of Gastroenterology 101:2, pages 380-384.
Crossref
Crossref
Robert J. C. Steele. (2006) Fecal Occult Blood Test Screening in the United Kingdom. The American Journal of Gastroenterology 101:2, pages 216-218.
Crossref
Crossref
Davide Mauri, George Pentheroudakis, Athanasios Milousis, Apostolos Xilomenos, Evaggelia Panagoulopoulou, Magdalini Bristianou, Georgios Zacharias, Dimitrios Christidis, Evaggelia Aikaterini Mustou, Athanasia Gkinosati & Nicholas Pavlidis. (2006) Colorectal cancer screening awareness in European primary care. Cancer Detection and Prevention 30:1, pages 75-82.
Crossref
Crossref
I. Sobhani & M. Abolhassani. 2006. Le dépistage du cancer colorectal. Le dépistage du cancer colorectal
43
55
.
Robert Steele. 2006. Challenges in Colorectal Cancer. Challenges in Colorectal Cancer
14
30
.
Sidney J. Winawer. (2005) Screening of Colorectal Cancer. Surgical Oncology Clinics of North America 14:4, pages 699-722.
Crossref
Crossref
Ismail Jatoi & William F. Anderson. (2005) Cancer Screening. Current Problems in Surgery 42:9, pages 620-682.
Crossref
Crossref
Karen Hughes, Barbara Leggett, Christopher Del Mar, John Croese, Stephen Fairley, John Masson, Joanne Aitkne, Alexandra Clavarino, Monika Janda, Warren R. Stanton, Shilu Tong & Beth Newman. (2005) Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Australian and New Zealand Journal of Public Health 29:4, pages 358-364.
Crossref
Crossref
D. Heresbach, S. Manfredi & J. F. Bretagne. (2005) Stratégies de dépistage du cancer colorectal: endoscopie versus autres modes d’explorationScreening strategies for CRC: endoscopy versus other modalities. Acta Endoscopica 35:4, pages 621-648.
Crossref
Crossref
RJC Steele. (2005) Implications of screening for colorectal cancer. Practice Nursing 16:3, pages 124-126.
Crossref
Crossref
Jack S. Mandel. (2005) Screening of patients at average risk for colon cancer. Medical Clinics of North America 89:1, pages 43-59.
Crossref
Crossref
Sidney J. Winawer. 2005. Tumor Prevention and Genetics III. Tumor Prevention and Genetics III
231
244
.
S. Tong, K. Hughes, B. Oldenburg & C. Del Mar. (2004) Would general practitioners support a population‐based colorectal cancer screening programme of faecal‐occult blood testing?. Internal Medicine Journal 34:9-10, pages 532-538.
Crossref
Crossref
Michael Pignone. (2004) Faecal occult-blood screening in Burgundy. The Lancet 364:9436, pages 741-742.
Crossref
Crossref
Christine A. Stone, Robert C. Carter, Theo Vos & James St John. (2004) Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests. Australian and New Zealand Journal of Public Health 28:3, pages 273-282.
Crossref
Crossref
Christine A. Stone, Robert C. Carter, Theo Vos & James St John. (2004) Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests. Australian and New Zealand Journal of Public Health 28:2, pages 273-282.
Crossref
Crossref
L. Paz-Valiñas & G. Atienza Merino. (2004) Cribado poblacional del cáncer colorrectal: una revisión sistemática. Gastroenterología y Hepatología 27:8, pages 450-459.
Crossref
Crossref
Paul J. Villeneuve & Ann Coombs. (2004) SCREENING FOR COLORECTAL CANCER USING THE FECAL OCCULT BLOOD TEST: AN ACTUARIAL ASSESSMENT OF THE IMPACT OF A POPULATION-BASED SCREENING PROGRAM IN CANADA. International Journal of Technology Assessment in Health Care 19:4, pages 715-723.
Crossref
Crossref
Wendy Atkin. 2003. Evidence‐based Oncology. Evidence‐based Oncology
151
163
.
A. Eickhoff, C. Maar, B. Birkner & J. F. Riemann. (2003) Dickdarmkrebs in Deutschland. Der Internist 44:3, pages 278-286.
Crossref
Crossref
Mark L. Welton, Madhulika G. Varma & Andreas Amerhauser. 2003. Essential Practice of Surgery. Essential Practice of Surgery
281
323
.
Peter Boyle & Maria Elena Leon. (2002) Epidemiology of colorectal cancer. British Medical Bulletin 64:1, pages 1-25.
Crossref
Crossref
M.J. Barry. (2002) Fecal occult blood testing for colorectal cancer: a perspective. Annals of Oncology 13:1, pages 61-64.
Crossref
Crossref
A.B. Lowenfels. (2002) Fecal occult blood testing as a screening procedure for colorectal cancer. Annals of Oncology 13:1, pages 40-43.
Crossref
Crossref
C. La Vecchia. (2002) Fecal occult blood screening for colorectal cancer: open issues. Annals of Oncology 13:1, pages 31-34.
Crossref
Crossref
M. Crespi & D. Lisi. (2002) Is colorectal cancer screening by fecal occult blood feasible?. Annals of Oncology 13:1, pages 47-50.
Crossref
Crossref
C.S. McArdle. (2002) Faecal occult blood testing for colorectal cancer. Annals of Oncology 13:1, pages 35-39.
Crossref
Crossref
Olive Craven. (2001) Screening for colorectal cancer using the faecal occult blood test: a critical literature review. European Journal of Oncology Nursing 5:4, pages 234-243.
Crossref
Crossref
Allan S. Detsky. (2001) Screening for Colon Cancer — Can We Afford Colonoscopy?. New England Journal of Medicine 345:8, pages 607-608.
Crossref
Crossref
C. La Vecchia. (2001) Reducing colorectal cancer through faecal occult blood screening: review of the evidence. Digestive and Liver Disease 33:6, pages 445-448.
Crossref
Crossref
F. Loeve, R. Boer, G.J. van Oortmarssen, M. van Ballegooijen & J.D.F. Habbema. (2001) Impact of systematic false-negative test results on the performance of faecal occult blood screening. European Journal of Cancer 37:7, pages 912-917.
Crossref
Crossref
Mark L. Welton, Madhulika G. Varma & Andreas Amerhauser. 2001. Surgery. Surgery
667
762
.
Shilu Tong, Karen Hughes, Brian Oldenburg, Christopher Del Mar & Bryan Kennedy. (2000) Socio‐demographic correlates of screening intention for colorectal cancer. Australian and New Zealand Journal of Public Health 24:6, pages 610-614.
Crossref
Crossref
Scott E Musinski. (2000) Preventable cancers: the role of obstetrician gynecologists in colorectal cancer screening. Primary Care Update for OB/GYNS 7:6, pages 238-243.
Crossref
Crossref
James S. Wu & Victor W. Fazio. (2000) Colon cancer. Diseases of the Colon & Rectum 43:11, pages 1473-1486.
Crossref
Crossref
. (2000) Recommendations on cancer screening in the European Union. European Journal of Cancer 36:12, pages 1473-1478.
Crossref
Crossref
Reid M Ness, Ann M Holmes, Robert Klein & Robert Dittus. (2000) Cost-Utility of One-Time Colonoscopic Screening for Colorectal Cancer at Various Ages. American Journal of Gastroenterology 95:7, pages 1800-1811.
Crossref
Crossref
Kyungran Shim. (2000) Part I. Colon cancer screening. Disease-a-Month 46:6, pages 368-380.
Crossref
Crossref
Douglas K. Rex & Reid M. Ness. (1999) Disease-Specific Outcomes Assessment for Diagnosis of Colorectal Neoplasia. Gastrointestinal Endoscopy Clinics of North America 9:4, pages 697-704.
Crossref
Crossref
Clifford L. Simmang, Peter Senatore, Ann Lowry, Terry Hicks, Marcus Burnstein, Frederick Dentsman, Victor Fazio, Edward Glennon, Neil Hyman, Bruce Kerner, John Kilkenny, Richard Moore, Walter Peters, Theodore Ross, Paul Savoca, Anthony Vernava & Douglas W. Wong. (1999) Practice parameters for detection of colorectal neoplasms. Diseases of the Colon & Rectum 42:9, pages 1123-1129.
Crossref
Crossref
R J C Steele. (2016) Screening for Colorectal Cancer. Scottish Medical Journal 44:3, pages 67-67.
Crossref
Crossref
R Houlston. (1999) Colorectal cancer screening. Critical Reviews in Oncology/Hematology 30:3, pages 183-187.
Crossref
Crossref
Barbara C. Tilley, Sally W. Vernon, Ronald Myers, Karen Glanz, Mei Lu, Kathryn Hirst & Alan R. Kristal. (1999) The Next Step Trial: Impact of a Worksite Colorectal Cancer Screening Promotion Program. Preventive Medicine 28:3, pages 276-283.
Crossref
Crossref
S. Anwar, C. Hall & J.B. Elder. (1998) Screening for colorectal cancer: present, past and future. European Journal of Surgical Oncology (EJSO) 24:6, pages 477-486.
Crossref
Crossref
Reid M Ness, Ann Holmes, Robert Klein, James Greene & Robert Dittus. (1998) Outcome States of Colorectal Cancer: Identification and Description Using Patient Focus Groups. American Journal of Gastroenterology 93:9, pages 1491-1497.
Crossref
Crossref
J. Norum. (1998) Prevention of colorectal cancer: A cost-effectiveness approach to a screening model employing sigmoidoscopy. Annals of Oncology 9:6, pages 613-618.
Crossref
Crossref
J Faivre & M.A Tazi. (1998) Should there be mass screening using faecal occult blood tests for colorectal cancer? Pro:. European Journal of Cancer 34:6, pages 773-776.
Crossref
Crossref
BP Towler, L Irwig, P Glasziou, D Weller & J Kewenter. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David LiebermanMDMD. (1998) How to Screen for Colon Cancer. Annual Review of Medicine 49:1, pages 163-172.
Crossref
Crossref
Dorte Gyrd-Hansen. (2009)
Fecal Occult Blood Tests:
A Cost-effectiveness Analysis
. International Journal of Technology Assessment in Health Care 14:2, pages 290-301.
Crossref
Crossref
Guy Launoy, Theresa C. Smith, Stephen W. Duffy & Véronique Bouvier. (1997) Colorectal cancer mass-screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. International Journal of Cancer 73:2, pages 220-224.
Crossref
Crossref
T. R. Church, J. S. Mandel & F. Ederer. (1997) Fecal Occult Blood Screening in the Minnesota Study: Sensitivity of the Screening Test. JNCI Journal of the National Cancer Institute 89:19, pages 1440-1448.
Crossref
Crossref
S. W. Vernon. (1997) Participation in Colorectal Cancer Screening: A Review. JNCI Journal of the National Cancer Institute 89:19, pages 1406-1422.
Crossref
Crossref
Robert J. C. Steele. (2016) Screening for Colorectal Cancer. Journal of Managed Care 1:3, pages 110-115.
Crossref
Crossref
M A Tazi, J Faivre, F Dassonville, J Lamour, C Milan & G Durand. (2016) Participation in Faecal Occult Blood Screening for Colorectal Cancer in a Well Defined French Population: Results of Five Screening Rounds from 1988 to 1996. Journal of Medical Screening 4:3, pages 147-151.
Crossref
Crossref
Haruhiko Shida, Kanako Ban, Masao Matsumoto, Kozo Masuda, Tomohiro Imanari, Takehisa Machida, Takashi Yamamoto & Tohru Inoue. (1996) Asymptomatic colorectal cancer detected by screening. Diseases of the Colon & Rectum 39:10, pages 1130-1135.
Crossref
Crossref
Jan Kewenter & Hans Brevinge. (1996) Endoscopic and surgical complications of work-up in screening for colorectal cancer. Diseases of the Colon & Rectum 39:6, pages 676-680.
Crossref
Crossref
Gabriel A. KuneGabriel A. Kune. 1996. Causes and Control of Colorectal Cancer. Causes and Control of Colorectal Cancer
29
46
.
Gabriel A. KuneGabriel A. Kune. 1996. Causes and Control of Colorectal Cancer. Causes and Control of Colorectal Cancer
287
334
.
Jack S. Mandel. 1996. Advances in Cancer Screening. Advances in Cancer Screening
51
76
.
P. Ferenci. 1995. Maligne gastrointestinale Tumoren. Maligne gastrointestinale Tumoren
15
26
.